Johnson & Johnson
JNJ
$255.74+0.97%
End of day · as of Oct 16, 2026, 4:02 PM ET
Mkt cap
$375.37B
EV/Sales
4.28
P/E ratio
29.7
FY2025 Revenue
$94.19B
EPS (TTM)
$8.62
Gross Margin (FY2025)
67.88%
Profit Margin (FY2025)
28.46%
Beta
0.41
Div yield
3.40%
Sector
Healthcare
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported JNJ revenue for 2025-12-28 was $94.19B. Net income was $26.80B. Revenue was up 6.0% from 2024-12-29 to 2025-12-28. JNJ currently screens at market cap $375.37B and trailing P/E 29.7.
Use this JNJ research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full JNJ income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Johnson & Johnson (JNJ) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Johnson & Johnson (JNJ) revenue for Dec 28, 2025 was $94.19B. Net income was $26.80B. Statements: https://lician.com/financials/jnj
Johnson & Johnson (JNJ) trailing P/E is 29.7 on the latest cached fundamentals snapshot.
Johnson & Johnson (JNJ) market capitalization is $375.37B on the latest cached snapshot.
Johnson & Johnson (JNJ) cached previous close $253.28; day range $255.52 – $255.74; volume 4,282,685. Session quote: https://lician.com/quote/jnj
Johnson & Johnson (JNJ) latest cached earnings event is "JNJ earnings" on Oct 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached JNJ filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/jnj